Certara Products Archives

Case Study

Early Value Assessment in Gene Therapy Clinical Trial Design

A global biotechnology company engineering precision genetic medicine for rare diseases was in need of…

CertaraFebruary 12, 2021

White Paper

Leveraging Biosimulation to Inform Optimal Use of COVID-19 Vaccines

CertaraFebruary 3, 2021

Brochure

BaseCase Interactive for Medical Affairs

CertaraJanuary 28, 2021

Brochure

BaseCase Market Access

CertaraNovember 30, 2020

Press Coverage

Getting Real with RWE

By Taren Grom Real-world evidence, important for regulatory decision-making, is beginning to touch all areas…

CertaraNovember 20, 2020

Case Study

Galderma Achieves FDA Approval of AKLIEF® (trifarotene)

In October 2019, Galderma announced that the U.S. FDA approved AKLIEF® (trifarotene) Cream, 0.005% for the…

CertaraNovember 9, 2020

White Paper

The Effects of COVID-19 on Stakeholder Engagement & Value Communication: Preparing for the New Normal

CertaraOctober 28, 2020

On-Demand Webinar

SNDS: Strengths, Limitations and Perspectives for the Largest and Richest Real-World Database in EU

In this webinar, our experts provided an overview of the SNDS and the key working…

CertaraOctober 20, 2020

Announcement

New Pinnacle 21 Community Validation Engine: FDA (1907.2)

In August 2020, we released our new Pinnacle 21 validation engine “FDA (1907.2)” for preparing…

CertaraSeptember 13, 2020

On-Demand Webinar

Exploring Common CDISC ADaM Dataset Conformance Findings

What you need to know when validating your CDISC ADAM datasets During the regulatory review…

CertaraSeptember 3, 2020

Certara Products